Editors in Conversation
A podcast by American Society for Microbiology
91 Episodes
-
The use of remdesivir against SARS-CoV-2 (AAC ed.)
Published: 11/2/2020 -
COVID-19 Diagnostic Testing Redux (JCM ed.)
Published: 10/16/2020 -
Discovering new antibiotics (AAC ed.)
Published: 10/5/2020 -
Parasites (JCM ed.)
Published: 9/18/2020 -
The dearth of antibiotic development (AAC ed.)
Published: 9/2/2020 -
Detection of carbapenemases (JCM ed.)
Published: 8/21/2020 -
New Vancomycin Guidelines (AAC ed.)
Published: 8/13/2020 -
COViD-19: Therapeutic Update (AAC ed.)
Published: 8/10/2020 -
Antimicrobial Agents and Chemotherapy Journal - Past, Present and Future (AAC ed.)
Published: 8/10/2020 -
Diagnostic Tests for COVID-19 (JCM ed.)
Published: 8/5/2020 -
Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)
Published: 8/4/2020
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.